Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.104.069401PMID 15229230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.

  2005cited by this paper
• Functional disassociation of the central and peripheral fatty acid amide signaling systems.

  2004cited by this paper
• Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

  2004cited by this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004influential reference
• Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility

  2003cited by this paper
• Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

  2003influential reference
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003influential reference
• Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.

  2003cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper
• Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

  2003influential reference
• Anandamide hydrolysis: a new target for anti-anxiety drugs?

  2003cited by this paper
• Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling

  2002cited by this paper
• CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

  2002cited by this paper
• Structure-function analysis of human triacylglycerol hydrolase by site-directed mutagenesis: identification of the catalytic triad and a glycosylation site.

  2002influential reference
• Chemical Approaches for Functionally Probing the Proteome*

  2002cited by this paper
• Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype

  2002cited by this paper
• The palmitoylethanolamide family: a new class of anti-inflammatory agents?

  2002influential reference
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001influential reference
• Leptin-regulated endocannabinoids are involved in maintaining food intake

  2001cited by this paper
• An anorexic lipid mediator regulated by feeding

  2001cited by this paper
• Profiling serine hydrolase activities in complex proteomes.

  2001cited by this paper
• Characterization of the Rodent Genes for Arylacetamide Deacetylase, a Putative Microsomal Lipase, and Evidence for Transcriptional Regulation* 210

  2001influential reference
• Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site‐directed probes

  2001influential reference
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

  2000cited by this paper
• Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

  2000cited by this paper
• Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

  2000cited by this paper
• Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.

  2000cited by this paper
• Activity-based protein profiling: the serine hydrolases.

  1999cited by this paper
• Pain modulation by release of the endogenous cannabinoid anandamide.

  1999cited by this paper
• Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition.

  1999cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• The anti‐hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

  1998cited by this paper
• SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.

  1998influential reference
• Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

  1997cited by this paper
• Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

  1997cited by this paper
• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  1996cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996influential reference
• Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*)

  1995cited by this paper
• Chemical characterization of a family of brain lipids that induce sleep.

  1995influential reference
• Anandamide Amidohydrolase Activity in Rat Brain Microsomes

  1995cited by this paper
• Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

  1995cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

  1993influential reference
• Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992influential reference

• Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025

  2026cites this paper
• Design of arylfurans as potential FAAH inhibitors: therapeutic potential in pain management.

  2025cites this paper
• Fatty acid binding proteins 5 and 7 differentially modulate phenotypic response to acute Δ9-tetrahydrocannabinol in female mice.

  2025cites this paper
• The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test

  2025cites this paper
• Expression and Kinetics of Endogenous Cannabinoids in the Brain and Spinal Cord of a Spare Nerve Injury (SNI) Model of Neuropathic Pain

  2022cites this paper
• The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?

  2021cites this paper
• Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application.

  2021cites this paper
• Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors

  2021cites this paper
• Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis

  2021cites this paper
• Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors.

  2020cites this paper
• The endocannabinoid system – current implications for drug development

  2020cites this paper
• Design, microwave‐assisted synthesis, biological evaluation and molecular modeling studies of 4‐phenylthiazoles as potent fatty acid amide hydrolase inhibitors

  2020cites this paper
• ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.

  2020cites this paper
• N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.

  2019cites this paper
• Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase α/β-Hydrolase Domain-Containing 12 (ABHD12).

  2019cites this paper
• Toward Atomistic Modeling of Irreversible Covalent Inhibitor Binding Kinetics

  2019cites this paper
• Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry.

  2019cites this paper
• Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.

  2019cites this paper
• Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.

  2019cites this paper
• Cannabinoid interventions for PTSD: Where to next?

  2019cites this paper
• Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.

  2019cites this paper
• Inhibition of fatty acid amide hydrolase in the insular cortex produces analgesic effects in neuropathic rats

  2018cites this paper
• Variations in EEG and motor functions related to COMT gene in patients with fibromyalgia

  2018cites this paper
• Medical Use of Cannabinoids

  2018cites this paper
• Brain activity of anandamide: a rewarding bliss?

  2018cites this paper
• Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors

  2018cites this paper
• Cannabinoids and Pain: New Insights From Old Molecules

  2018cites this paper
• Factors Affecting Pain Intensity and Postoperative Oxycodone Requirement : Clinical and Genetic Perspectives

  2018cites this paper
• Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.

  2018cites this paper
• Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors

  2018influential citation
• Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

  2018cites this paper
• The role of the endocannabinoid system in the emotional modulation of pain

  2018cites this paper
• Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice.

  2018cites this paper
• Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats

  2018cites this paper
• A Perspective on the Kinetics of Covalent and Irreversible Inhibition

  2017cites this paper
• A chemical genetic screen uncovers a small molecule enhancer of the N-acylethanolamine degrading enzyme, fatty acid amide hydrolase, in Arabidopsis

  2017cites this paper
• Interactions of Cannabinoids With Biochemical Substrates

  2017cites this paper
• In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor

  2017cites this paper
• Design of Benzoxathiazin-3-one 1,1-Dioxides as a New Class of Irreversible Serine Hydrolase Inhibitors: Discovery of a Uniquely Selective PNPLA4 Inhibitor.

  2017cites this paper
• Title Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor

  2017influential citation
• Metabolism of N-Acylethanolamines: To Phase II and Back Again

  2017cites this paper
• Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors

  2017cites this paper
• The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry–Biology Interface

  2017cites this paper
• Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems—A Novel Treatment Option for Chronic Pain Management

  2016cites this paper
• FAAH inhibitors in the limelight, but regrettably

  2016cites this paper
• Intracellular Self-Assembly of Cyclic d-Luciferin Nanoparticles for Persistent Bioluminescence Imaging of Fatty Acid Amide Hydrolase.

  2016cites this paper
• Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

  2016cites this paper
• Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.

  2016cites this paper
• Chemical-induced alterations in the endocannabinoid system in mouse skin

  2016cites this paper
• Application of Molecular Modelling studies to the search of novel approaches for neuroprotection and stem cells applications

  2016cites this paper
• Pain modulation from the brain during diabetic neuropathy: Uncovering the role of the rostroventromedial medulla.

  2016cites this paper
• Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists.

  2016cites this paper
• Lipases and their inhibitors in health and disease.

  2016cites this paper
• The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress.

  2015cites this paper
• The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review.

  2015cites this paper
• Endocannabinoid Catabolic Enzymes Play Differential Roles in Thermal Homeostasis in Response to Environmental or Immune Challenge

  2015cites this paper
• Metabolic Enzymes for Endocannabinoids and Endocannabinoid-Like Mediators

  2015cites this paper
• The role of the endocannabinoid system in pain.

  2015cites this paper
• Physiological Role of Endocannabinoid-Hydrolyzing Enzymes in Brain Development and Neurodegeneration

  2015cites this paper
• Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety

  2015cites this paper
• Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist

  2015cites this paper
• Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014)

  2015cites this paper
• Molecular Dynamics Analysis of FAAH Complexed with Anandamide

  2015cites this paper
• A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

  2015cites this paper
• Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

  2015cites this paper
• Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants

  2015influential citation
• Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.

  2014cites this paper
• Conference on ‘ PUFA mediators: implications for human health ’ Symposium 3: Cannabinoids in human health Endocannabinoid system and pain: an introduction

  2014cites this paper
• Conference on ‘ PUFA mediators : implications for human health ’ Symposium 3 : Cannabinoids in human health Elevating endocannabinoid levels : pharmacological strategies and potential therapeutic applications

  2014cites this paper
• Classical endocannabinoid‐like compounds and their regulation by nutrients

  2014cites this paper
• PET Imaging of Fatty Acid Amide Hydrolase with [18F]DOPP in Nonhuman Primates

  2014cites this paper
• α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.

  2014cites this paper
• Long‐term consequences of perinatal fatty acid amino hydrolase inhibition

  2014influential citation
• No more pain upon Gq‐protein‐coupled receptor activation: role of endocannabinoids

  2014influential citation
• Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides

  2014cites this paper
• Design, Synthesis, and Characterization of α-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase

  2014cites this paper
• The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury.

  2014cites this paper
• Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.

  2014cites this paper
• Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis

  2014cites this paper
• The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.

  2014cites this paper
• In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects

  2014influential citation
• Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.

  2014cites this paper
• Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.

  2014cites this paper
• Latest advances in the discovery of fatty acid amide hydrolase inhibitors

  2013cites this paper
• The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1‐ and FAAH‐independent mechanisms

  2013influential citation
• Endocannabinoids and N-acylethanolamines in translational pain research : from monoacylglycerol lipase to muscle pain

  2013cites this paper
• A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.

  2013cites this paper
• Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors.

  2013cites this paper
• Effect of diet on tissue levels of palmitoylethanolamide.

  2013cites this paper
• Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

  2013cites this paper
• Targeting the cannabinoid system for pain relief?

  2013cites this paper
• The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.

  2013cites this paper
• Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics

  2013cites this paper
• Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.

  2013cites this paper
• Endocannabinoid system and pain: an introduction

  2013cites this paper
• Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-α in brain.

  2013cites this paper
• Cannabinoid receptors and pain

  2013cites this paper
• Participación de la anandamida en la liberación de los espermatozoides del epitelio oviductal bovino

  2013cites this paper
• Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system

  2013cites this paper
• Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

  2013cites this paper